The Microbiome & You: Why Your Gut Rules Everything

If someone told you that the most important organ in your body was not your heart or your brain, but the trillions of microorganisms living inside your intestines, you might be sceptical. But the science is increasingly clear: the gut microbiome is not just involved in digestion. It is a central regulator of immunity, metabolism, mood, and long-term disease risk. Understanding it — and knowing when it needs help — is one of the most important things you can do for your health.

A Universe Within You

The human gut microbiome comprises approximately 38 trillion microorganisms — roughly equal to the total number of human cells in the body. These organisms include bacteria, fungi, viruses, and archaea, collectively forming an ecosystem of staggering complexity. They weigh approximately 1.5 to 2 kilograms and contain more genes than the human genome itself.

This is not an inert population of passengers. The gut microbiome is a metabolically active organ in its own right. It ferments dietary fibre to produce short-chain fatty acids — butyrate, propionate, and acetate — which nourish the cells lining the colon, regulate inflammation, and influence metabolism throughout the body. It synthesises vitamins including vitamin K and several B vitamins. It metabolises bile acids, drugs, and environmental toxins. It trains and calibrates the immune system from infancy.

Perhaps most remarkably, it communicates directly with the brain via the gut-brain axis — a bidirectional signalling network that involves the vagus nerve, immune mediators, and microbially-produced neurotransmitters. The gut produces approximately 95 percent of the body's serotonin and a significant proportion of its dopamine and GABA. This is not metaphor — it is molecular biology, and it explains why gut health has such profound effects on mood, cognition, and mental wellbeing.

What Is Dysbiosis?

Dysbiosis is the medical term for an imbalanced or disrupted gut microbiome. It can manifest as a loss of microbial diversity (the total number of different species present), an overgrowth of potentially harmful organisms, or a depletion of beneficial species. In practice, all three often occur simultaneously.

The causes of dysbiosis are numerous and often cumulative. Antibiotic use is the most dramatic — a single course of broad-spectrum antibiotics can eliminate entire bacterial populations and alter the microbiome for months or even permanently. But other factors contribute as well: a diet low in fibre and high in processed foods, chronic stress, inadequate sleep, excessive alcohol consumption, chronic proton pump inhibitor use, and environmental factors such as pesticide exposure.

The consequences of dysbiosis extend far beyond digestive symptoms. Research has linked an imbalanced microbiome to conditions as diverse as obesity, type 2 diabetes, cardiovascular disease, autoimmune conditions including inflammatory bowel disease and rheumatoid arthritis, allergic diseases, depression and anxiety, and even neurodegenerative conditions like Parkinson's disease. While the microbiome is rarely the sole cause of these conditions, it is increasingly recognised as a significant contributing and modulating factor.

Signs Your Microbiome May Need Attention

Not every digestive symptom indicates dysbiosis, and not every patient needs microbiome-specific intervention. However, certain patterns should raise the index of suspicion.

Chronic bloating and gas that persist despite dietary modifications are a common indicator. Persistent changes in bowel habits — particularly after antibiotic use or a gastrointestinal infection — may suggest that the microbiome has not fully recovered. Unexplained fatigue, brain fog, and mood changes that co-occur with digestive symptoms often point to a gut-mediated process.

Recurrent infections — whether Clostridioides difficile, urinary tract infections, or candidal overgrowth — may indicate that the microbiome's colonisation resistance has been compromised. Food intolerances that seem to be worsening or multiplying over time can also be a sign of dysbiosis, as an imbalanced microbiome can impair the gut's ability to process certain foods.

Microbiome Testing: Beyond the Basics

At our clinic, we use advanced microbiome sequencing to assess the composition and diversity of the gut flora. This is not a standard stool culture — it is a comprehensive genomic analysis that identifies the full spectrum of organisms present and their relative abundances.

This information is clinically valuable because it allows us to assess microbial diversity, identify specific deficiencies or overgrowth patterns, determine whether a patient is a suitable candidate for FMT, and guide donor selection for transplantation programs. Microbiome testing transforms gut health management from guesswork to precision medicine.

Restoring the Microbiome

For patients with significant dysbiosis, restoration strategies may include dietary optimisation with emphasis on prebiotic fibre to nourish beneficial bacteria, targeted probiotic supplementation where evidence supports specific strains for specific conditions, and in cases of severe or treatment-resistant dysbiosis, Faecal Microbiota Transplantation.

FMT is the most powerful microbiome restoration tool available. By transplanting a complete, diverse microbial ecosystem from a screened donor, FMT can achieve what diet and probiotics alone cannot — a wholesale replacement of a damaged ecosystem with a thriving one. Our FMT program uses three delivery methods (fresh enema, capsule, and transcolonic infusion) and is guided by microbiome testing to ensure optimal donor-recipient matching.

Our donor screening protocols exemplify precision medicine. Every donor undergoes comprehensive medical history review, extensive infectious disease screening (bacterial, viral, and parasitic), and critically, microbiome diversity analysis via high-resolution sequencing. We assess richness (the number of distinct bacterial species), evenness (the distribution of abundance across species), and overall Shannon diversity index to ensure the donor microbiome is sufficiently robust to provide therapeutic benefit. A donor with good health but limited microbiome diversity may provide insufficient therapeutic benefit.

Treatment programs are individualised. Recurrent C. difficile infection typically responds to a single FMT infusion (98 percent success). IBS often benefits from a three-month program with multiple administrations, allowing progressive restoration of microbial stability. Ulcerative colitis may require a six-month program with careful monitoring of symptom and inflammatory marker improvement. The duration and delivery method — fresh enema, capsule, or transcolonic infusion — are selected based on the patient's anatomy, tolerance, and clinical picture.

For patients with specific conditions such as recurrent C. diff, IBS, or ulcerative colitis, FMT offers documented improvement rates of 98 percent, 65 percent, and 70 percent respectively in our practice. These represent dramatic improvements over the natural history of these conditions or conventional pharmacological therapy alone.

Our choice of delivery method for each patient is individualised. Fresh enema-based FMT is our most economical option and is ideal for patients comfortable with the procedure. Capsule-based FMT offers maximal convenience and is particularly valuable for patients who are needle-phobic or who have severe anal sphincter dysfunction. Transcolonic infusion provides the most precise placement — delivering the donor material directly to the caecum or ascending colon where it can take root. For patients with multiple prior FMT failures, transcolonic infusion is often the preferred method.

The duration of FMT programs varies with the condition and severity. A single fresh enema or capsule is often sufficient for recurrent C. difficile. Patients with IBS typically benefit from a three-month program with multiple administrations. Those with ulcerative colitis often require a six-month program with careful monitoring of clinical and inflammatory parameters. This staged approach allows us to assess response as the transplanted microbiome establishes itself and to adjust the treatment plan if needed.

The Future of Microbiome Medicine

We are still in the early chapters of understanding the gut microbiome, but the trajectory is unmistakable. Microbiome science is moving rapidly from research curiosity to clinical reality. Personalised microbiome-based treatments, precision probiotic formulations, and microbiome-guided pharmacotherapy are all on the horizon.

At our clinic, we are at the forefront of this evolution. From microbiome mapping to FMT to gastric microbiome transplantation, we are committed to translating the latest science into practical treatments that make a real difference in our patients' lives.

The gut microbiome is not a trend or a fad. It is the biological foundation of health — and restoring it when it fails is one of the most impactful things modern medicine can do.

If you are concerned about your gut health, experiencing chronic symptoms that have not been explained, or simply interested in understanding your microbiome better, we welcome you to get in touch. Your gut has been talking to you — it is time to listen.